Diagnosis and therapy of multiple myeloma
The Korean Journal of Internal Medicine
;
: 263-273, 2013.
Artigo
em Inglês
| WPRIM
| ID: wpr-35113
ABSTRACT
Many advances in the treatment of multiple myeloma have been made due to the use of transplantation and the introduction of novel agents including thalidomide, lenalidomide, and bortezomib. The first step is recognizing the symptoms and starting prompt treatment. Different strategies should be selected for young and elderly subjects. Young patients are commonly eligible for transplantation, which is now considered the standard approach for this setting, and various inductions therapies containing novel agents are available before transplantation. Elderly patients are usually not eligible for transplantation, and gentler approaches with new drugs combinations are used for their treatment.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Prognóstico
/
Pirazinas
/
Talidomida
/
Ácidos Borônicos
/
Fatores Etários
/
Transplante de Células-Tronco
/
Fatores Imunológicos
/
Mieloma Múltiplo
/
Antineoplásicos
Tipo de estudo:
Estudo diagnóstico
/
Estudo prognóstico
Limite:
Humanos
Idioma:
Inglês
Revista:
The Korean Journal of Internal Medicine
Ano de publicação:
2013
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS